Back
ProShares UltraPro MidCap400 Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
60
UMDD
ProShares UltraPro MidCap400
Last Price:
27.84
Seasonality Move:
14.04%
Sell
44
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Buy
60
ProShares UltraPro MidCap400 (UMDD)
is a Buy
Is ProShares UltraPro MidCap400 a Buy, Sell or Hold?
- The current ProShares UltraPro MidCap400 [UMDD] share price is $28.04. The Score for UMDD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- UMDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UMDD Stock Price Chart
What is ProShares UltraPro MidCap400's stock price today?
-
The ProShares UltraPro MidCap400 share price today is $28.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UMDD is experiencing slight buying pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $39.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
UMDD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 64.29 | Buy |
| Chaikin Money Flow: | 7909 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.43 - 27.03) | Buy |
| Bollinger Bands (100): | (23.75 - 26.73) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 44.04 | Sell |
| Chaikin Money Flow: | 27576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.13 - 42.69) | Sell |
| Bollinger Bands (100): | (27.3 - 41.42) | Buy |
UMDD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.62 | Buy |
| 20-day SMA: | 25.73 | Buy |
| 50-day SMA: | 25.67 | Buy |
| 200-day SMA: | 24.19 | Buy |
| 8-day EMA: | 26.17 | Buy |
| 20-day EMA: | 25.65 | Buy |
| 50-day EMA: | 25.41 | Buy |
| 200-day EMA: | 23.95 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.48 | Sell |
| 20-day SMA: | 41.45 | Sell |
| 50-day SMA: | 40.72 | Sell |
| 200-day SMA: | 31.06 | Buy |
| 8-day EMA: | 40.12 | Sell |
| 20-day EMA: | 40.8 | Sell |
| 50-day EMA: | 39.41 | Sell |
| 200-day EMA: | 32.87 | Buy |
ProShares UltraPro MidCap400 Earnings Growth & UMDD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
ProShares UltraPro MidCap400 Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||